CC
AGN

Centiva Capital’s Allergan plc AGN Stock Holding History

Centiva Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-267,000
Closed -$51M – 1022
2019
Q4 		$51M Buy
267,000
+258,800
+3,156% +$46.7M 2.49% 4
2019
Q3 		$1.38M Hold
8,200
– – 0.08% 191
2019
Q2 		$1.37M Hold
8,200
– – 0.08% 186
2019
Q1 		$1.2M Sell
8,200
-3,300
-29% -$478K 0.08% 160
2018
Q4 		$1.54M Buy
11,500
+1,900
+20% +$311K 0.12% 116
2018
Q3 		$1.83M Buy
+9,600
New +$1.76M 0.16% 84

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Centiva Capital's AGN Position: Q2 2020 in Review

Centiva Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 36,930 shares — an estimated $6.54M sold.

Centiva Capital first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $6.54M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Centiva Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Centiva Capital sold 36,930 Allergan plc shares in Q2 2020, an estimated $6.54M.
  • Centiva Capital first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Centiva Capital's Allergan plc position peaked at $6.54M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Centiva Capital's 13F filing for Q2 2020, filed 14 Aug 2020.